Weiss Multi-Strategy Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-62,589
Closed -$7.62M 494
2023
Q4
$7.62M Buy
62,589
+13,707
+28% +$1.53M 0.18% 147
2023
Q3
$5.49M Buy
+48,882
New +$6.21M 0.13% 210
2023
Q1
Sell
-47,397
Closed -$6.04M 752
2022
Q4
$6.04M Sell
47,397
-3,040
-6% -$353K 0.17% 193
2022
Q3
$5.27M Buy
50,437
+27,011
+115% +$2.96M 0.14% 229
2022
Q2
$2.46M Buy
+23,426
New +$2.78M 0.07% 350
2021
Q2
Sell
-21,143
Closed -$3.29M 825
2021
Q1
$3.29M Buy
21,143
+3,175
+18% +$492K 0.07% 333
2020
Q4
$2.69M Buy
+17,968
New +$2.54M 0.05% 365
2020
Q2
Sell
-15,450
Closed -$1.52M 626
2020
Q1
$1.52M Buy
+15,450
New +$2.03M 0.06% 271
2014
Q2
Sell
-3,245
Closed -$298K 956
2014
Q1
$298K Buy
3,245
+721
+29% +$66.5K 0.01% 823
2013
Q4
$228K Sell
2,524
-906
-26% -$78.4K ﹤0.01% 875
2013
Q3
$274K Buy
+3,430
New +$270K 0.01% 679

Other funds holding ZBH

Weiss Multi-Strategy Advisers's ZBH Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 62,589 shares — an estimated $7.62M sold.

Weiss Multi-Strategy Advisers first reported a position in ZBH in Q3 2013 and held it in 11 quarters. The position peaked at $7.62M in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 62,589 Zimmer Biomet shares in Q1 2024, an estimated $7.62M.
  • Weiss Multi-Strategy Advisers first reported a position in Zimmer Biomet in Q3 2013 and held it in 11 quarters.
  • Weiss Multi-Strategy Advisers's Zimmer Biomet position peaked at $7.62M in Q4 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.